Hayley M. McDaid - Concepedia

Author

Hayley M. McDaid

Albert Einstein College of Medicine ORCID

Also Known As

H M McDaid, H. M. McDaid, H. McDaid, H.M. McDaid, Hayley M McDaid, Hayley M. McDaid, Hayley McDaid, McDaid, H.M., Nazia S Jamil

Publications

2.4K

Citations

H-Index

Concepts

All Affiliations

Albert Einstein College of Medicine Montefiore Medical Center Yeshiva University University of Pennsylvania New York University

About

Hayley M. McDaid is an author at Albert Einstein College of Medicine specializing in medicine, tumor biology, and cell biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	8	8	518
2	Cell Biology	7	7	423
3	Cellular Physiology	2	2	33
4	Biochemistry	1	1	44
5	Biomolecular Engineering	1	1	44

Hayley M. McDaid

Publications

1.4K

Citations

H-Index

Page 1

	Year	Citations
A Novel Indication for Panobinostat as a Senolytic Drug in NSCLC and HNSCC Leleesha Samaraweera, Alfred Adomako, Alicia Rodriguez‐Gabin, Scientific Reports	2017	171
Taxol and discodermolide represent a synergistic drug combination in human carcinoma cell lines. Laura Martello, Hayley M. McDaid, Donna Lee Regl, PubMed Chemoprevention StrategyPathologyCell DeathCell CycleTumor Biology	2000	169
Phase I Clinical and Pharmacokinetic Study of BMS-247550, a Novel Derivative of Epothilone B, in Solid Tumors Sridhar Mani, Hayley M. McDaid, Anne Hamilton, Clinical Cancer Research	2004	158
N-cadherin/FGFR promotes metastasis through epithelial-to-mesenchymal transition and stem/progenitor cell-like properties Xia Qian, Amy Anzovino, S. Kim, Oncogene Developmental BiologyMedicineCell-matrix InteractionStem Cell ResearchEpithelial-mesenchymal Interactions	2013	125
Selective Potentiation of Paclitaxel (Taxol)-Induced Cell Death by Mitogen-Activated Protein Kinase Kinase Inhibition in Human Cancer Cell Lines Hayley M. McDaid, Susan Band Horwitz Molecular Pharmacology	2001	109
Validation of the pharmacodynamics of BMS-247550, an analogue of epothilone B, during a phase I clinical study. Hayley M. McDaid, Sridhar Mani, Heng Jia Shen, PubMed Cell DeathPathologyPharmacotherapyMetronomic ChemotherapyExperimental Pharmacology	2002	95
Enhancement of the Therapeutic Efficacy of Taxol by the Mitogen-Activated Protein Kinase Kinase Inhibitor CI-1040 in Nude Mice Bearing Human Heterotransplants Hayley M. McDaid, Lluís López-Barcons, Aaron Grossman, Cancer Research	2005	90
Targeting Protein Translation in Human Non–Small Cell Lung Cancer via Combined MEK and Mammalian Target of Rapamycin Suppression Marie-Emmanuelle Legrier, Chia‐Ping Huang Yang, Han-Guang Yan, Cancer Research	2007	83
Potentiation of Taxol Efficacy by Discodermolide in Ovarian Carcinoma Xenograft-Bearing Mice Gloria S. Huang, Lluís López-Barcons, B. Scott Freeze, Clinical Cancer Research	2006	76
Increased expression of the RIα subunit of the cAMP-dependent protein kinase A is associated with advanced stage ovarian cancer Hayley M. McDaid, Michael T. Cairns, R. Atkinson, British Journal of Cancer	1999	61

Page 1